Besides, BPC 157 as an anti-ulcer peptide antagonizes hepatomegaly, fatty liver, increased AST, ALT and amylase serum values, breakdown of liver glycogen with profound hypoglycemia, along with calcium deposition after huge insulin over-dose application (31)
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis
10.3389/fnagi.2022.810483 34 GieryskaM.Szulc-DbrowskaL.StruzikJ.MielcarskaM
Adverse Reactions/Side Effects The following serious adverse reactions are described below or elsewhere in the prescribing information: Risk of Thyroid C-cell Tumors [see Warnings and Precautions (5.1)] Acute Pancreatitis [see Warnings and Precautions (5.2)] Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin [see Warnings and Precautions (5.3)] Hypersensitivity Reactions [see Warnings and Precautions (5.4)] Acute Kidney Injury Due to Volume Depletion [see Warnings and Precautions (5.5)] Severe Gastrointestinal Adverse Reactions [see Warnings and Precautions (5.6)] Diabetic Retinopathy Complications in Patients with a History of Diabetic Retinopathy [see Warnings and Precautions (5.7)] Acute Gallbladder Disease [see Warnings and Precautions (5.8)] Pulmonary Aspiration During General Anesthesia or Deep Sedation [see Warnings and Precautions (5.9)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice
Rather than targeting a single mechanism, it simultaneously promotes blood vessel formation (angiogenesis), enhances growth factor signaling, increases nitric oxide for better tissue oxygenation, and suppresses inflammatory markers
No data points were excluded from experiments or analyses
